[HTML][HTML] Cysteine metabolic circuitries: druggable targets in cancer
VDB Bonifácio, SA Pereira, J Serpa… - British journal of cancer, 2021 - nature.com
To enable survival in adverse conditions, cancer cells undergo global metabolic
adaptations. The amino acid cysteine actively contributes to cancer metabolic remodelling …
adaptations. The amino acid cysteine actively contributes to cancer metabolic remodelling …
Metabolic reprogramming of chemoresistant cancer cells and the potential significance of metabolic regulation in the reversal of cancer chemoresistance
X Chen, S Chen, D Yu - Metabolites, 2020 - mdpi.com
Metabolic reprogramming is one of the hallmarks of tumors. Alterations of cellular
metabolism not only contribute to tumor development, but also mediate the resistance of …
metabolism not only contribute to tumor development, but also mediate the resistance of …
Focus on ferroptosis regulation: exploring novel mechanisms and applications of ferroptosis regulator
TL Ma, JX Chen, P Zhu, CB Zhang, Y Zhou, JX Duan - Life Sciences, 2022 - Elsevier
Ferroptosis is a kind of iron-dependent regulatory necrosis characterized by the fatal
accumulation of iron-dependent lipid peroxides in the plasma membrane and the final …
accumulation of iron-dependent lipid peroxides in the plasma membrane and the final …
Targeting glutathione metabolism: partner in crime in anticancer therapy
E Desideri, F Ciccarone, MR Ciriolo - Nutrients, 2019 - mdpi.com
Glutathione (GSH) is the predominant low-molecular-weight antioxidant with a ubiquitous
distribution inside the cell. The steady-state level of cellular GSH is dependent on the …
distribution inside the cell. The steady-state level of cellular GSH is dependent on the …
A platinum (IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance
P Fronik, M Gutmann, P Vician, M Stojanovic… - Communications …, 2022 - nature.com
Clinical efficacy of oxaliplatin is frequently limited by severe adverse effects and therapy
resistance. Acquired insensitivity to oxaliplatin is, at least in part, associated with elevated …
resistance. Acquired insensitivity to oxaliplatin is, at least in part, associated with elevated …
Ovarian cancer biomarkers: moving forward in early detection
VDB Bonifácio - Tumor Microenvironment: The Main Driver of Metabolic …, 2020 - Springer
Ovarian cancer is a silent cancer which rate survival mainly relays in early stage detection.
The discovery of reliable ovarian cancer biomarkers plays a crucial role in the disease …
The discovery of reliable ovarian cancer biomarkers plays a crucial role in the disease …
Oxidative stress-inducing anticancer therapies: taking a closer look at their immunomodulating effects
Cancer cells are characterized by higher levels of reactive oxygen species (ROS) compared
to normal cells as a result of an imbalance between oxidants and antioxidants. However …
to normal cells as a result of an imbalance between oxidants and antioxidants. However …
Glutathione in ovarian cancer: a double-edged sword
SC Nunes, J Serpa - International journal of molecular sciences, 2018 - mdpi.com
Glutathione (GSH) has several roles in a cell, such as a reactive oxygen species (ROS)
scavenger, an intervenient in xenobiotics metabolism and a reservoir of cysteine. All of these …
scavenger, an intervenient in xenobiotics metabolism and a reservoir of cysteine. All of these …
Targeting oxidatively induced DNA damage response in cancer: opportunities for novel cancer therapies
P Davalli, G Marverti, A Lauriola… - Oxidative medicine and …, 2018 - Wiley Online Library
Cancer is a death cause in economically developed countries that results growing also in
developing countries. Improved outcome through targeted interventions faces the scarce …
developing countries. Improved outcome through targeted interventions faces the scarce …
Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease management
Resistance to platinum-based chemotherapy is a major clinical challenge in ovarian cancer,
contributing to the high mortality-to-incidence ratio. Management of the platinum-resistant …
contributing to the high mortality-to-incidence ratio. Management of the platinum-resistant …